Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 9 versions Re-verified since Aug 18, 2022, no change to tracked fieldsv28-v36
  2. Primary endpoints: 1 to 3v27 Show 9 more changesShow less
    • Primary completion date: May 2034 to May 1, 2034
    • Study completion date: May 2035 to May 1, 2035
    • Start date: May 2006 to May 19, 2006
    • Interventions: Data Collection (Behavioral) to Biospecimen Collection (Procedure), Electronic Health Record Review (Other)
    • Eligibility criteria shortened, about 29 words
    • Secondary endpoints expanded, about 14 words
    • Study description shortened, about 186 words
    • Study site revised
    • Study title expanded, about 2 words
  3. Re-verified, no change to tracked fieldsv26
  4. Study completion date: May 2034 to May 2035v25
  5. Re-verified, no change to tracked fieldsv24
Show 22 earlier versionsHide 22 earlier versions
  1. Study completion date: May 2034v23
  2. 3 versions Re-verified since Dec 14, 2015, no change to tracked fieldsv20-v22
  3. Enrollment target: 1600 to 2000
    • Study description shortened, about 4 words
    v19
  4. Re-verified, no change to tracked fieldsv18
  5. Enrollment target: 1000 to 1600
    • Study description revised
    • Study site revised
    • Eligibility criteria expanded, about 2 words
    v17
  6. 3 versions Re-verified since Mar 15, 2013, no change to tracked fieldsv14-v16
  7. Study description shortened, about 7 wordsv13
  8. 3 versions Re-verified since Aug 17, 2011, no change to tracked fieldsv10-v12
  9. Phase: Not applicable to Not specifiedv9
  10. Re-verified, no change to tracked fieldsv8
  11. Study site revisedv7
  12. Primary endpoint revised
    • Secondary endpoints shortened, about 24 words
    v6
  13. Re-verified, no change to tracked fieldsv5
  14. Primary endpoint revised
    • Secondary endpoints expanded, about 24 words
    v4
  15. Primary endpoints: 3 to 1v3 Show 5 more changesShow less
    • Primary completion date: May 2034
    • Study completion date: May 2034 to not stated
    • Secondary endpoints shortened, about 21 words
    • Study description shortened, about 11 words
    • Eligibility criteria expanded, about 3 words
  16. Phase: Not specified to Not applicable
    • Study completion date: May 2034
    • Study arms: 0 to 1
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Trial Details
NCT Number NCT00488878
Lead Sponsor M.D. Anderson Cancer Center
Conditions
(from sponsor)		 Low Grade Ovarian Serous Adenocarcinoma, Malignant Ovarian Neoplasm, Ovarian Carcinoma, Primary Peritoneal Carcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Psammocarcinoma
Related terms Ovarian Neoplasms
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov